Document:

EX-10.5

 Exhibit 10.5 
  

 
 June 16, 2015 

Dear Sandy: 
 LaserLock Technologies, Inc. (the
“Company”) is pleased to offer you (“you” and its correlatives) full-time employment as Chief Technology Officer. 

You agree to devote your full-time and best efforts to the business and interests of the Company and its affiliates, and to abide by and carry
out the Company’s policies and procedures from time to time in effect. 
 1. Compensation. You will be entitled to a base salary
computed at an annual rate of $150,000 (pro rated for partial years). All payments will be made net of all applicable withholding taxes and in accordance with the Company’s then-current payroll practices (currently, two times per month). In
addition, subject to approval by the Company’s Board of Directors, you will be awarded, on a one-time basis, 31,875,000 options (the “Options”) to purchase a total of 31,875,000 shares of common stock of the Company, par value
$0.01 (the “Option Shares”), vesting quarterly over three years, under the Company’s 2013 Comprehensive Incentive Compensation Plan Equity Incentive Plan. The Options will be evidenced by, and subject to the terms of, an Option
Agreement, a form of which is attached hereto as Exhibit A. In addition, subject to approval by the Company’s Board of Directors, you will be awarded, on a one-time basis, 19,125,000 restricted stock units (the “RSUs”)
related to the Company’s common stock, $0.01 par value per share (the “RSU Shares”), vesting over a three year period with one-third vesting on the one-year anniversary of commencing employment and one-twelfth vesting ratably
on a quarterly basis thereafter, under the Company’s 2013 Comprehensive Incentive Compensation Plan. The RSUs will be evidenced by, and subject to the terms of, a Restricted Stock Unit Agreement, a form of which is attached hereto as Exhibit
B. In addition, on an annual basis, or such other period to be determined by the Company, you shall be entitled to be considered for a bonus. The size of such periodic bonus and the criterion for receipt of such periodic bonus shall be
determined by the Company. The Options and RSUs are subject to adjustment, as provided in the Plan, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after the date hereof. Furthermore, should the
company affect a reverse stock split prior to the employee’s start date, the amount of Options and RSUs provided for in this offer letter should be adjusted to account for the reverse stock split. 

2. Employee Benefits. As a full-time employee, you will be eligible to participate in all benefit programs that are generally available
to the Company’s employees, including Company-subsidized medical, dental, and vision insurance coverage and, at your election, life insurance and/or long-term disability coverage. Additionally, you will be eligible to take up to four
(4) weeks of paid time off per year. 
  

			
	 LASERLOCK TECHNOLOGIES, INC.
		Telephone: (202) 400-3700
	 3112 M Street NW
		Facsimile: (202) 400-3701
	 Washington, DC 20007
		

  

 June 16, 2015 

Page 2 of 3 
  

 3. Policies and Procedures. As an employee of the Company, you will be required to
comply with all applicable state and federal regulations, and internal compliance policies and procedures in effect from time to time. 
 4.
Representations and Warranties. You represent and warrant to the Company that (i) your agreement to the terms of this letter agreement and the performance of your duties and obligations contemplated hereunder will not violate or conflict
with the provisions of any other agreement, understanding or order to which you are a party or by which you are bound; (ii) you have never been suspended, censured, or otherwise subjected to any disciplinary action or other proceeding, and you
have not been notified that you are the subject of any investigation that could result in any such suspension, censor, or other disciplinary action, by any federal, state, or foreign governmental entity, by the attorney disciplinary authorities of
any state, or by any securities or commodity exchange or self-regulatory organization; and (iii) you know of nothing that could result in any determination by the finder of fact in any action or matter (whether civil, criminal, regulatory or
otherwise) relating to the circumstances of your employment with any previous employer(s) that would either: (A) adversely affect your ability to fully perform your duties as an employee of the Company in the capacities described herein, or
(B) would by their nature cause material harm to your reputation and good standing within the Company’s industry, or to the reputation of the Company or its affiliates. Any exceptions to the foregoing must be described in factual detail
and attached to this letter agreement. 
 5. Confidentiality, Non-Disclosure, and Non-Interference Agreement. As a condition of your
employment with the Company, you will be required to sign the attached Non-Disclosure and Non-Solicitation Agreement (“NDA”), which is hereby incorporated herein by reference. 

6. Employment at Will. You hereby acknowledge and agree that your employment with the Company is at will. This means that although we
hope your employment relationship with us will be long-term, either you or the Company may terminate this relationship with or without cause at any time and without any prior notice, in which case your obligations under the NDA will continue in full
force and effect as specified therein. Neither this letter nor any other communication should be construed as a contract of employment for a particular period of time. The nature of your employment relationship may not be changed, except by written
agreement. 
 7. Entire Agreement. This agreement and the NDA constitute your entire agreement with respect to matters set forth
herein and therein, and supersede any prior agreement(s) with respect thereto. Any changes or waiver of any of the terms of this agreement must be in writing signed by both you and the Company. The failure of the Company at any time to require
performance of any of your obligations under this agreement shall in no manner affect its right to enforce the same at a later date. No waiver by the Company of any condition, or of any breach, of this agreement shall be deemed to be or construed as
a further or continuing waiver of any such condition or breach. 

*        *        * 

  

 

 
 [Signature Page to Letter Agreement] 

Please confirm your agreement to the foregoing by signing and returning one copy of this agreement to the Company. 

If you have any questions, please feel free to contact us. We look forward to working with you. 

 

			
	Sincerely,
	
	LASERLOCK TECHNOLOGIES, INC.
		
	By:		  

			Paul A. Donfried
			Chief Executive Officer

  

	
	Accepted and agreed as of the date
	first written above:
	
	  

	SANDY FLIDERMANEX-10.6

 Exhibit 10.6 

INDEPENDENT DIRECTOR’S AGREEMENT 

This INDEPENDENT DIRECTOR’S AGREEMENT (the “Agreement”) is made as of June 12, 2015 by and between LaserLock
Technologies, Inc., a Nevada corporation (hereinafter referred to as the “Company”), and Jonathan Weinberger (the “Director”). 

BACKGROUND 

WHEREAS, the Board of Directors of the Company (the “Board of Directors”) desires to appoint the Director to perform
the duties of an “independent” director (within the meaning of the rules of the U.S. Securities and Exchange Commission (the “SEC”)) and, potentially in the future, on committees of the Board of Directors, and the Director
desires to be so appointed for such position(s) and to perform the duties required of such position(s) in accordance with the terms and conditions of this Agreement. 

AGREEMENT 
 NOW,
THEREFORE, in consideration for the above recited promises and the mutual promises contained herein, and for other good and valuable consideration, the adequacy and sufficiency of which are hereby acknowledged, the Company and the Director
hereby agree as follows: 
 1. DUTIES. The Company requires that the Director be available to perform the duties customarily related
to an independent director as may be determined and assigned by the Board of Directors and as may be required by the Company’s constituent instruments, including its certificate of incorporation, by-laws and its corporate governance and board
committee charters, each as amended or modified from time to time, and by applicable law, including, without limitation, the Nevada Revised Statutes (the “NRS”) and the rules and regulations of the SEC, any exchange or quotation
system on which the Company’s securities may be traded from time to time and all other applicable legal or regulatory requirements. Initially, the Company and the Director have agreed that the Director will serve as (i) Chair of the Board
of Directors, and (ii) Chair of the Nominating and Corporate Governance Committee. The Director agrees to devote as much time as is necessary to perform completely the duties as an independent director in accordance with such Company
requirements, including duties as a member of committees of the Board of Directors as the same may be established from time to time. The Director will attend all meetings of Board of Directors and its committees as the Director may be appointed to,
in person or by teleconference. The Director will perform such duties described herein in accordance with the general fiduciary duty of directors arising under the NRS. 

2. TERM. The appointment is subject to the Board of Directors determining, both initially and from time to time, that the Director
meets the definition of “independent” under the applicable rules of the SEC and the market on which the Company’s shares are traded or listed for quotation. The term of this Agreement shall commence as of the date hereof and shall
continue until December 31, 2015 or his earlier death, incapacity, removal or resignation; provided, however, that this Agreement shall automatically continue for successive one (1) year terms beginning each December 31 unless
terminated in accordance with the terms hereof. The Board of Directors or a designated committee thereof shall have the discretion to nominate or decline to nominate the Director for election at each annual or applicable special meeting of the
Company’s stockholders, and the failure to nominate the Director as, if and when such nominations are made shall be deemed a termination of this Agreement for purposes of Section 8 hereof. 

  
 1 

 3. COMPENSATION. Subject to the approvals by the Compensation Committee or the Board of
Directors, for all duties and services to be performed by the Director hereunder, the Director may be entitled to earn cash fees under guidelines and rules established by the Company from time to time for compensating non-employee directors for
serving on, and attending meetings of, committees of its Board of Directors and the boards of directors of its subsidiaries. In addition to the cash fees described above, the Company may grant the Director options to purchase or restricted shares of
the Company’s common stock (collectively, the “Shares”) under the Company’s director compensation plans adopted from time to time. No registration rights are hereby granted with respect to the Shares. 

Initial compensation for the Lead Outside Director will consist of: 

 

					
	1)				8,500,000 Stock Options per year of Service, vesting over 2 years according to the following schedule:
			a.		2,833,333 Stock Options upon acceptance
			b.		2,833,333 Stock Options after 12 months
			c.		2,833,334 Stock Options after 24 months
			
	2)				6,375,000 Stock Options as a one-time grant for extraordinary service to the company, vesting over 2 years according to the following schedule:
			a.		2,125,000 Stock Options upon acceptance
			b.		2,125,000 Stock Options after 12 months
			c.		2,125,000 Stock Options after 24 months

 4. MARKET STAND-OFF AGREEMENT. In the event of a public or private offering of the Company’s
securities and upon request of the Company, the underwriters or placement agents placing the offering of the Company’s securities, the Director agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise
dispose of any of the Shares other than those included in the registration, without the prior written consent of the Company or such underwriters, as the case may be, for such period of time from the effective date of such registration as may be
requested by the Company or such placement agent or underwriter. 
 5. EXPENSES. In addition to the compensation provided in
paragraph 3 hereof, the Company will reimburse the Director for pre-approved reasonable business related expenses incurred in good faith in the performance of the Director’s duties for the Company including attending meetings of the Board of
Director and its committees as the Director may be appointed to. Such payments shall be made by the Company upon submission by the Director of a signed statement itemizing the expenses incurred. Such statement shall be accompanied by sufficient
documentary matter to support the expenditures. 

  
 2 

 6. OTHER AGREEMENTS. 

(a) CONFIDENTIAL INFORMATION AND INSIDER TRADING. The Company and the Director each acknowledge that, in order for the intents and
purposes of this Agreement to be accomplished, the Director shall necessarily be obtaining access to certain confidential information concerning the Company and its affairs, including, but not limited to, business methods, information systems,
financial data and strategic plans which are unique assets of the Company (as further defined below, the “Confidential Information”) and that the communication of such Confidential Information to third parties could irreparably
injure the Company and its business. Accordingly, Director agrees that, during his association with the Company and thereafter, he will treat and safeguard as confidential and secret all Confidential Information received by him at any time and that,
without the prior written consent of the Company, he will not disclose or reveal any of the Confidential Information to any third party whatsoever or use the same in any manner except in connection with the business of the Company and in any event
in no way harmful to or competitive with the Company or its business. For purposes of this Agreement, “Confidential Information” means any information not generally known to the public or recognized as confidential according to standard
industry practice, any trade secrets, know-how, development, manufacturing, marketing and distribution plans and information, inventions, formulas, methods or processes, whether or not patented or patentable, pricing policies and records of the
Company (and such other information normally understood to be confidential or otherwise designated as such in writing by the Company), all of which Director expressly acknowledges and agrees shall be confidential and proprietary information
belonging to the Company. Upon termination of his association with the Company, Director shall return to the Company all documents and papers relating to the Company, including any Confidential Information, together with any copies thereof, or
certify that he has destroyed all such documents and papers. Furthermore, Director recognizes that the Company has received and in the future will receive confidential or proprietary information from third parties subject to a duty on the
Company’s part to maintain the confidentiality of such information and, in some cases, to use it only for certain limited purposes. Director agrees that Director owes the Company and such third parties, both during the term of Directors
association with the Company and thereafter, a duty to hold all such confidential or proprietary information in the strictest confidence and not to, except as is consistent with the Company’s agreement with the third party, disclose it to any
person or entity or use it for the benefit of anyone other than the Company or such third party, unless expressly authorized to act otherwise by an officer of the Company. In addition, Director acknowledges and agrees that Director may have access
to “material non-public information” for purposes of the federal securities laws (“Insider Information”) and that the Director will abide by all securities laws relating to the handling of and acting upon such Insider
Information. Further, Director agrees to sign an acknowledgement certifying that Director has reviewed the Company’s Insider Trading Manual, which is attached hereto as Exhibit A, and understands the policies and procedures contained
therein and agrees to be bound by them. 
 (b) DISPARAGING STATEMENTS. At all times during and after the period in which Director is
a director of the Board of Directors and at all times thereafter, Director shall not either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the Company, any of its affiliates, any of
their respective officers, directors, shareholders, employees and agents, or any of the Company’s current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the
reputation or goodwill of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates; provided, however, that nothing in this paragraph shall preclude the

  
 3 

 Director from complying with all obligations imposed by law or legal compulsion, and provided, further, however,
that nothing in this paragraph shall be deemed applicable to any testimony given by Director in any legal or administrative proceedings. 
 The Company has
issued a policy requiring its employees to avoid using statements that reasonably could be viewed as disparaging the Company’s directors, officers, employees, customers, members, associates or suppliers. Examples of such conduct might include
offensive online posts meant to intentionally harm someone’s reputation. 
 (c) ENFORCEMENT. The Director acknowledges and
agrees that the covenants contained herein are reasonable, that valid consideration has been and will be received and that the agreements set forth herein are the result of arms-length negotiations between the parties hereto. The Director recognizes
that the provisions of this Section 6 are vitally important to the continuing welfare of the Company and its affiliates and that any violation of this Section 6 could result in irreparable harm to the Company and its affiliates for which
money damages would constitute a totally inadequate remedy. Accordingly, in the event of any such violation by the Director, the Company and its affiliates, in addition to any other remedies they may have, shall have the right to institute and
maintain a proceeding to compel specific performance thereof or to obtain an injunction or other equitable relief restraining any action by the Director in violation of this Section 6 without posting any bond therefore or demonstrating actual
damages, and Director will not claim as a defense thereto that the Company has an adequate remedy at law or require the posting of a bond. If any of the restrictions or activities contained in this Section 6 shall for any reason be held by a
court of competent jurisdiction to be excessively broad as to duration, geographical scope, activity or subject, such restrictions shall be construed so as thereafter to be limited or reduced to be enforceable to the extent compatible with the
applicable law; it being understood that by the execution of this Agreement the parties hereto regard such restrictions as reasonable and compatible with their respective rights. Director acknowledges that injunctive relief may be granted
immediately upon the commencement of any such action without notice to Director and in addition Company may recover monetary damages. 
 (d)
SEPARATE AGREEMENT. The parties hereto further agree that the provisions of Section 6 are separate from and independent of the remainder of this Agreement and that Section 6 is specifically enforceable by the Company notwithstanding
any claim made by Director against the Company. The terms of this Section 6 shall survive termination of this Agreement. 
 7.
NOTICE OF MATERIAL CHANGE IN FINANCIAL CONDITION OF THE COMPANY. The Company shall endeavor to notify the Director in writing, at the earliest practicable time, of (i) any material adverse change in the financial condition of the Company
and (ii) any changes to the Company’s officers, C-level executives, general counsel (if any), or controller. 
 8.
TERMINATION. With or without cause, Director may terminate this Agreement and Director’s director position with the Company at any time upon ten (10) days written notice to the Company. In such event, the Company shall be obligated to
pay to the Director the compensation and expenses incurred in accordance with this Agreement due up to the date of the termination. 
  

  
 4 

 Prior to the expiration of the term of this Agreement, the Company may terminate this Agreement and
Director’s director position with the Company for Cause by giving written notice to Director setting forth the date of termination. As used herein, the term “Cause” shall be limited to the following grounds: 

 

	    i.	a failure of Director to materially perform assigned duties and responsibilities set forth herein, after notice from the Company and failure to cure within ten (10) business days after delivery of such notice;

  

	   ii.	any gross negligence, malfeasance, willful misconduct, theft, fraud, embezzlement on the part of Director or other criminal financial malfeasance by Director against the Company; 

 

	  iii.	Director’s arrest or indictment for the commission of a felony or crime of moral turpitude under the laws of the United States or any state thereof; 

 

	  iv.	the commencement by any federal, state, or local agency or authority of an investigation of Director if the Company determines it to be injurious to the financial condition or business reputation of the Company;

  

	   v.	Director’s material breach of this Agreement or any of the Company’s written rules, policies and/or procedures, after notice from the Company and failure to cure within ten (10) business days after
delivery of such notice; 

  

	  vi.	Director’s disability, ninety (90) days after Director becomes disabled; 

  

	 vii.	any other act or omission by Director that is injurious to the financial condition or business reputation of the Company; or 

  

	viii.	any intentional misconduct by Director, whether or not in the course of services as a member of the Board of Directors of the Company, which has a material adverse effect on the financial condition or reputation of the
Company. 

 Nothing contained herein or omitted herefrom shall prevent the stockholders of the Company from removing Director with immediate
effect at any time for any reason or voting for or against the nomination of Director to serve as such at any annual or special meeting of the Company’s stockholders. 

9. INDEMNIFICATION; INSURANCE. The Company shall indemnify, defend and hold harmless the Director, to the full extent allowed by the
law of the State of Delaware, and as provided by, or granted pursuant to the Company’s Certificate of Incorporation (as amended and/or restated from time to time) (the “COI”), By-laws (as amended and/or restated from time to
time) (the “By-Laws”), or any agreement, vote of stockholders or disinterested directors or otherwise, both as to action in the Director’s official capacity and as to action in another capacity relating to the Company’s
business while holding such office except for matters arising out of the Director’s gross negligence or willful misconduct. Such indemnification shall cover payment for or reimbursement of expenses (including legal fees and expenses) to the
fullest extent provided for in the COI and the By-Laws. The Company’s compliance with the following insurance provision shall not relieve the Company from liability under this indemnity provision. 

The Company shall have and maintain at its sole cost and expense throughout the term of this Agreement and for six (6) years thereafter, directors’
and officers’ insurance from a recognized insurance company with coverage in an amount no less than $[ • ]. The stipulated limits of coverage shall not be construed as a limitation of any potential liability of the Company, and failure to
request evidence of this insurance by Director shall in no way be construed as a waiver of the Company’s obligation to provide the insurance coverage specified. The insurance policy shall provide that it may not be canceled or amended in a
manner which restricts the existing coverage without at least thirty (30) days prior written notice to Director. Within thirty (30) days after this 

  
 5 

 
Agreement is fully executed, (and thereafter at least thirty (30) days prior to the expiration of insurance coverage), the Company shall furnish to Director a Certificate of Insurance
evidencing the foregoing coverage and specifically listing Director as a member of the Board of Directors of the Company. 
 10.
AMENDMENTS; WAIVERS. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment, by the Company and the Director or, in the case of a waiver, by the party against whom enforcement
of any such waiver is sought. No waiver of any breach with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent breach or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. 

11. NOTICE. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and
kept on file by the sending party); or (iii) one (1) business day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same. The addresses and
facsimile numbers for such communications shall be: 
  

			
	If to the Company:
		
	Attention:		Chief Executive Officer
	Address:		8th Floor
			12 Twenty First Street
			New York, NY 10010
	Facsimile:		+1 (646) 532-6775
		
	If to the Director:		
		
	Attention:		Jonathan Weinberger
	Address:		As listed in Exhibit “B”

 or to such other address and/or facsimile number and/or to the attention of such other Person as the recipient party has
specified by written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,
(B) mechanically or electronically generated by the sender’s facsimile machine containing the time, date, recipient facsimile number and an image of the first page of such transmission or (C) provided by an overnight courier service
shall be rebuttable evidence of personal service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively. 

12. GOVERNING LAW AND DISPUTE RESOLUTION. This Agreement shall be interpreted in accordance with, and the rights of the parties hereto
shall be determined by the laws of Nevada without reference to its conflicts of laws principles. Should a dispute arise between the parties under or relating to this Agreement, each party agrees that prior to initiating any formal proceeding against
the other (except when injunctive relief is appropriate), the parties will each designate a representative for 

  
 6 

 
purposes of resolving the dispute. If the parties’ representatives are unable to resolve the dispute within 14 business days, the dispute shall be settled by mediation and then, if
necessary, by arbitration under the then-current commercial arbitration rules of the American Arbitration Association. The location of the proceeding shall be in New York, NY. The award in any such arbitration shall be final, binding, conclusive and
not appealable. Judgment upon any award rendered by the arbitrator may be entered by any court having jurisdiction thereof. 
 13.
ASSIGNMENT. The rights and benefits of the Company under this Agreement shall be transferable, and all the covenants and agreements hereunder shall inure to the benefit of, and be enforceable by or against, its successors and assigns. The duties
and obligations of the Director under this Agreement are personal and therefore the Director may not assign any right or duty under this Agreement without the prior written consent of the Company. 

14. SEVERABILITY. If any provision of this Agreement shall be declared invalid or illegal, for any reason whatsoever, then,
notwithstanding such invalidity or illegality, the remaining terms and provisions of the this Agreement shall remain in full force and effect in the same manner as if the invalid or illegal provision had not been contained herein. 

15. HEADINGS; CONSTRUCTION. The section headings contained in this Agreement are for reference purposes only and shall not affect in
any way the meaning or interpretation of this Agreement. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any
party. 
 16. NO THIRD-PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person or entity. 

17. WITHHOLDING. The Company may withhold from any and all amounts payable under this Agreement such federal, state, local and foreign
taxes as may be required to be withheld pursuant to any applicable law or regulation. 
 18. ENTIRE AGREEMENT. Subject to the
provisions of the NRS and the Company’s certificates of incorporation and bylaws, this Agreement and the exhibit hereto sets forth the entire agreement of the parties with respect to its subject matter and supersedes all prior agreements,
promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party to this Agreement with respect to such subject matter. 

19. COUNTERPARTS. This Agreement may be executed in any number of counterparts, all of which shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format
(.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an
original thereof. Execution and delivery of this Agreement by facsimile or other electronic signature is legal, valid and binding for all purposes. 

[Signature Page Follows] 

[Remainder of page intentionally left blank.] 

  
 7 

 [Signature Page to Independent Director’s Agreement] 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered as of the day and year first above
written. 
  

			
	LASERLOCK TECHNOLOGIES, INC.
		
	By:		 
			Paul Donfried
			Chief Executive Officer

  

	
	DIRECTOR
	
	  

	Jonathan Weinberger
	
	DIRECTOR
	
	  

	Claudio Ballard

  
 8 

 EXHIBIT A 

[Insider Trading Manual] 

  
 9 

 EXHIBIT B: DIRECTOR’S HOME ADDRESS 

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]